The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics

Por Goldvaser, Hadar, Rizel, Shulamith, Hendler, Daniel, Neiman, Victoria, Shepshelovich, Daniel, Shochat, Tzippy, Sulkes, Aaron, Brenner, Baruch, Yerushalmi, Rinat
Publicado no Int J Endocrinol (2016)

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis

Por Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona, Granot, Tal, Rizel, Shulamith, Stemmer, Salomon M.
Publicado em 2014

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study

Por Margel, David, Benjaminov, Ofer, Ozalvo, Rachel, Shavit Grievink, Liat, Kedar, Inbal, Yerushalmi, Rinat, Ben-Aharon, Irit, Neiman, Victoria, Yossepowitch, Ofer, Kedar, Daniel, Levy, Zohar, Shohat, Mordechai, Brenner, Baruch, Baniel, Jack, Rosenbaum, Eli
Publicado no BMC Cancer (2014)

Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib

Por Keizman, Daniel, Sarid, David, Lee, Jae L., Sella, Avishay, Gottfried, Maya, Hammers, Hans, Eisenberger, Mario A., Carducci, Michael A., Sinibaldi, Victoria, Neiman, Victoria, Rosenbaum, Eli, Peer, Avivit, Neumann, Avivit, Mermershtain, Wilmosh, Rouvinov, Keren, Berger, Raanan, Yildiz, Ibrahim
Publicado no Oncologist (2016)